Toxic psychosis? Duration of untreated psychosis, symptomatology and cognitive deterioration in first episode psychosis

Irish Journal of Psychological Medicine

Volumn 24, Issue 4, 2007, Pages 145-148

  Lawoyin, Richard ^a   Gaynor, Keith ^a,b   Dooley, Barbara ^b   Lawlor, Elizabeth ^c   Clarke, Mary ^d   O'callaghan, Eadbhard ^d,e  

^a Blackrock Co Dublin   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c DETECT   (Ireland)

^d St John of God Hospitaller Services Ireland   (Ireland)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cognitive functioning; DUP; Duration of untreated psychosis; Psychosis; Schizophrenia

Indexed keywords

EID: 84899718276     PISSN: 07909667     EISSN: 20516967     Source Type: Journal    
DOI: 10.1017/S0790966700010582     Document Type: Article

References (35)

1. Norman RMG, Malla KA. Duration of untreated psychosis: a critical evaluation of the concept and its importance. Psychol Med 2001; 31: 381–400.
2. Skeate A, Jackson C, Birchwood M, Jones C. Duration of untreated psychosis and pathways to care in first episode psychosis: investigation of help seeking behaviour in primary care. Br J Psychiatry (Suppl) 2002; 181(43): S73-S77.
3. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173–6.
4. Harris MG et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005; 79: 85–93.
5. Keshavan MS, Berger G, Zipursky RB, Wood SJ, Pantelis C. Neurobiology of early psychosis. Br J Psychiatry (Suppl) 2005; 187: S8-S18.
6. Wyatt R. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res 1991; 5: 201–2.
7. Harrop CE, Trower P. Why does schizophrenia develop at late adolescence? Chichester: Wiley, 2003.
8. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426–445.
9. Byrne M et al. Neuropsychology, genetic liability and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol 2002; 112: 38–48.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington DC: American Psychiatric Association, 1994.
11. Beiser M, Erickson D, Fleming JAE, lacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349–1354.
12. Andreasen NC. The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa, 1983b.
13. Andreasen NC. The scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa, 1983a.
14. Malla AK, Norman RM, Manchada R. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002; 32: 1109–1119.
15. Thorup A et al. Integrated treatment ameliorates negative symptoms in first episode psychosis - results from the Danish OPUS trial. Schizophr Res 2005; 79: 95–105.
16. Taylor D, Patton C, Kerwin R. The South London and Maudsley NHS Trust Prescribing Guidelines (7th ed). Martin Dunitz: London, 2003.
17. ORYGEN Early Psychosis Service. First Episode Psychosis Survey Guidelines. Personal Communication. Melbourne, 2005
18. Wechsler D. Wechsler Adult Intelligence Scale (3rd ed). New York: Psychological Corporation, 1997a.
19. Wechsler D. Wechsler Test of Adult Reading. New York: Psychological Corporation, 2001.
20. Conners CK. CPT: Connors' Continuous Performance Test. Toronto: Multi-Health Systems, 1995.
21. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary. London: Oxford University Press, 1991.
22. Lezack MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
23. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural Assessment of the Dysexecutive Syndrome. St Edmunds, UK: Thames Valley Test Company, 1996.
24. Wechsler D. The measurement and appraisal of adult intelligence. Baltimore: Williams and Wilkins Company, 1958.
25. Amminger GP, Edwards J, McGorry PD. Estimating cognitive deterioration in schizophrenia. Br J Psychiatry 2002; 181: 164.
26. Russsell AJ, Munro J, Jones PB, Hayward P, Hemsely DR, Murray RM. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br J Clin Psychol 2000; 39: 297–305
27. Bilder RM, Mukherjee S, Rieder RO, Pandurangi AK. Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11: 409–419
28. Norman RMG, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first episode patients. Br J Psychiatry 2001; 179: 340–5.
29. Friss S et al. Effects of an early detection program on duration of untreated psychosis: part of the Scandinavian TIPS study. Br J Psychiatry (Suppl) 2005; 48: S29-S32.
30. Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharm 2005; 8: 457–472.
31. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008–1014.
32. Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999; 25: 201–222.
33. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD. Duration of untreated psychosis and cognitive deterioration in first episode schizophrenia. Schizophr Res 2002; 54: 223–230.
34. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177: 207–211.
35. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62(9): 975–983.